[PDF] Top 20 Rev. Bras. Hematol. Hemoter. vol.39 número3
Has 10000 "Rev. Bras. Hematol. Hemoter. vol.39 número3" found on our website. Below are the top 20 most common "Rev. Bras. Hematol. Hemoter. vol.39 número3".
Rev. Bras. Hematol. Hemoter. vol.39 número3
... Human leukocyte antigen (HLA) haplotype frequencies calculated for alleles in high linkage disequilibrium may predict for non-HLA antigen match versus mismatch.. There is increasing evid[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.39 número3
... Table 1 – Original and Portuguese version of Blood/Injection Fear Scale and the results of content validity ratio (CVR). estimated for each item[r] ... See full document
8
Rev. Bras. Hematol. Hemoter. vol.39 número3
... Results: Thirty-three patients were evaluated. The median age at the beginning of medica- tion administration was 29 years. Patients had received a median of five prior therapies. Overall response rate was 45.4%, with 13 ... See full document
7
Rev. Bras. Hematol. Hemoter. vol.39 número3
... procedures: 39 to esophagogastroduodenoscopy, 23 to colonoscopy, four to capsular videoendoscopy (preceded by radiologic study of gastrointestinal tract in all four cases) and 11 to bone mar- row ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.39 número3
... The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia. Stei[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.39 número3
... months after starting TKI therapy to monitor therapy, if the RqPCR international scale (IS) is not available, at 12 months if complete cytogenetic remission (CCR) or major molecular resp[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.39 número3
... In immunocompromised hosts, the infection may man- ifest with aplastic crisis, chronic anemia or ITP.. 8 In patients.[r] ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.39 número3
... 21. Heinicke T, Hütten H, Kalinski T, Franke I, Bonnekoh B, Fischer T. Sustained remission of blastic plasmacytoid dendritic cell neoplasm after unrelated allogeneic stem cell transplantation – a single center ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.39 número3
... This prompted a diagno- sis of peripheral blood and bone marrow involvement by a small cell component of an ALK+ ALCL of the composite vari- ant (showing common type features in the sero[r] ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.39 número3
... Nutritional assessment and serum zinc and copper concentration in leukemic children. Garófolo A, Lopez FA, Petrilli AS[r] ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.39 número3
... Thrombin generated in the thrombin generation test can be quantified as platelet-rich or platelet-poor plasma using the calibrated automated thrombogram method, which monitors the cleava[r] ... See full document
7
Rev. Bras. Hematol. Hemoter. vol.39 número3
... Results: The cases included were 78 chronic lymphocytic leukemias, three atypical chronic lymphocytic leukemias, six marginal zone lymphomas, 11 splenic marginal zone lym- phomas, nine l[r] ... See full document
7
Rev. Bras. Hematol. Hemoter. vol.39 número3
... Assessment of the Matos & Carvalho index for distinguishing thalassemia from iron deficiency anemia.. Rev Bras Hematol Hemoter.[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.39 número3
... The objective of this study was to compare miRNA expression profiles of patients with Binet A chronic lymphocytic leukemia with those of sub- jects with high-count monoclonal B-cell lymp[r] ... See full document
7
Rev. Bras. Hematol. Hemoter. vol.39 número3
... Know- ing the human leukocyte antigens allele group and haplotype frequencies as well as the linkage disequilibrium between alleles of different human leukocyte antigens loci can shorten[r] ... See full document
8
Rev. Bras. Hematol. Hemoter. vol.39 número3
... Table 2 – Prevalence of chronic medical conditions in patients with and without iron deficiency anemia in elderly subjects aged 60 years and more. Chronic medical conditions Iron deficie[r] ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.39 número3
... The molecular response profile of patients with samples in all time intervals ( n = 82) showed in the first interval (three to five months) that 78.1% (64/82) had 1 log reduction in the [r] ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.39 número3
... Figure 3 – No significant difference in event-free survival was found for acute lymphoblastic leukemia children with no antibodies compared to those with immunoglobulin (Ig)G, IgE or bot[r] ... See full document
8
Rev. Bras. Hematol. Hemoter. vol.39 número3
... (iii) By using quantitative fluorescent beads labeled with a known number of phycoerythrin (PE) molecules, the curve of fluorescence intensity can be extrapolated to evaluate the number [r] ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.39 número3
... Quantitative monitoring of the percentage of the fusion tran- script BCR-ABL1 (breakpoint cluster region – c-Abelson murine leukemia oncogene 1, non-receptor tyrosine kinase) by reverse [r] ... See full document
2
temas relacionados